We are pleased to announce that the following companies already confirmed to give a presentation in the programme:
apheris AI, BVMA, CeGaT, Cube Biotech, Curetis, CureVac, CORAT-Consortium, Eisbach Bio, Ethris, HB Technologies, Immunic, Novartis, Paul-Ehrlich-Institut, Proteona, QIAGEN, Thermo Fisher Scientific, TRIGA-S and Yumab.
The coronavirus pandemic is a crisis for everyone. Societies all over the world are struggling with rising infection rates and an increasing death toll. Also Germany has been hit hard, but so far has managed to keep the number of death victims comparatively low, not only but also due to an excellent social health system with sufficient intensive care units.
German pharma and biotech companies have massively extended their research and development efforts to develop and produce diagnostics and to find therapies and vaccines.
More than 50 of the BIO Deutschland member companies work to prevent, diagnose or treat the virus infection.
The virtual event German Corona Showcase will combine presentations and partnering. The programme will present German companies that are developing diagnostics, therapies and vaccines against the corona virus. But as the corona pandemic also has a considerable impact on companies that are currently not working on the coronavirus; we also invite these companies to present and to report on their current situation.
The full conference experience requires a fee-based registration:
Register HERE for the online B2B Partnering
To follow the live web seminars only, please register HERE